Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Jun 03
With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer.
Related Questions
Assume slowly rising PSA in a low risk prostate cancer patient with negative PSMA PET CT. If so, what dose and what would you cover? If not, when woul...
New answer by (February 8, 2024)
I would not offer further local therapy in this situation, especially given that there is no direct evidence of disease within a usual post-operative treatment field. I would ...